Interaction between body mass index and hormone-receptor status as a prognostic factor in lymph-node-positive breast cancer.
The aim of this study was to determine the relationship between the body mass index (BMI) at a breast cancer diagnosis and various factors including the hormone-receptor, menopause, and lymph-node status, and identify if there is a specific patient subgroup for which the BMI has an effect on the bre...
Main Authors: | Il Yong Chung, Jong Won Lee, Ji Sung Lee, Yu Rang Park, Yul Ha Min, Yura Lee, Tae In Yoon, Guiyun Sohn, Sae Byul Lee, Jisun Kim, Hee Jeong Kim, Beom Seok Ko, Byung Ho Son, Sei Hyun Ahn |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5331962?pdf=render |
Similar Items
-
Prognosis according to clinical and pathologic lymph node status in breast cancer patients who underwent sentinel lymph node biopsy alone after neoadjuvant therapy.
by: Sae Byul Lee, et al.
Published: (2021-01-01) -
Survival outcome of adjuvant endocrine therapy alone for patients with lymph node-positive, hormone-responsive, HER2-negative breast cancer
by: Sung Ui Jung, et al.
Published: (2019-10-01) -
Sentinel node biopsy alone for breast cancer patients with residual nodal disease after neoadjuvant chemotherapy
by: Jung Whan Chun, et al.
Published: (2021-04-01) -
The effects of poloxamer and sodium alginate mixture (Guardix-SG®) on range of motion after axillary lymph node dissection: A single-center, prospective, randomized, double-blind pilot study.
by: Sae Byul Lee, et al.
Published: (2020-01-01) -
BCT score predicts chemotherapy benefit in Asian patients with hormone receptor-positive, HER2-negative, lymph node-negative breast cancer.
by: Mi Jeong Kwon, et al.
Published: (2018-01-01)